Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025

Description

Cancer immunotherapy drug discovery outsourcing is a specialized service model within the pharmaceutical and biotech sectors. It involves entrusting aspects of cancer immunotherapy drug development to external service providers, typically contract research organizations (CROs) or contract development and manufacturing organizations (CDMOs). This approach accelerates innovation by leveraging external expertise and resources, allowing pharmaceutical companies to concentrate on their core activities.

The primary drug types involved in cancer immunotherapy drug discovery outsourcing include monoclonal antibodies, immunomodulators, oncolytic viral therapies, cancer vaccines, and others. Monoclonal antibodies are laboratory-made molecules that mimic the immune system's ability to target specific proteins on cancer cells, aiding in fighting off harmful pathogens. The services provided encompass target identification and validation, lead screening and characterization, and cell-based assays utilized in therapeutic areas such as lung cancer, breast cancer, melanoma, and others.

The cancer immunotherapy drug discovery outsourcing market research report is one of a series of new reports from The Business Research Company that provides cancer immunotherapy drug discovery outsourcing market statistics, including cancer immunotherapy drug discovery outsourcing industry global market size, regional shares, competitors with a cancer immunotherapy drug discovery outsourcing market share, detailed cancer immunotherapy drug discovery outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the cancer immunotherapy drug discovery outsourcing industry. This cancer immunotherapy drug discovery outsourcing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cancer immunotherapy drug discovery outsourcing market size has grown rapidly in recent years. It will grow from $1.5 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth in the historic period can be attributed to increasing cases of adverse drug reactions, increasing demand for comprehensive genomic testing, increasing global incidence of cancer, a growing need for targeted therapy, and a growing number of clinical trials.

The cancer immunotherapy drug discovery outsourcing market size is expected to see rapid growth in the next few years. It will grow to $2.57 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. The growth in the forecast period can be attributed to the rising importance of personalized medicine, increasing diagnostic tests, increasing focus on personalized cancer therapy, increasing healthcare expenditure, and increasing cancer incidence and awareness. Major trends in the forecast period include advancements in diagnostic technologies, next-generation sequencing (NGS), integration of artificial intelligence (AI), liquid biopsy technologies, the development of point-of-care companion diagnostic devices, and innovative testing technologies.

The escalating expenses associated with research and development (R&D) are projected to drive the expansion of the cancer immunotherapy drug discovery outsourcing market. The substantial R&D costs stem from the necessity of specialized expertise, costly equipment, and the inherent risks linked with innovation. The outsourcing of drug discovery activities taps into the economies of scale provided by contract research organizations (CROs), enabling smaller biotech firms and startups to optimize their R&D budgets and allocate resources more efficiently, thereby enhancing cost-effectiveness. For instance, in June 2023, as reported by the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical R&D expenditure in Europe reached $49,500 million (€44,500 million) in 2022, marking a rise of around 6.45% from $46,500 million (€42,533 million) in 2021. Consequently, the exorbitant costs associated with in-house research and development are fueling the growth of the cancer immunotherapy drug discovery outsourcing market.

Key players in the cancer immunotherapy drug discovery outsourcing market are embracing a strategic partnership approach to bolster cancer drug production and gain competitive advantages. Strategic partnerships typically involve collaborative relationships among two or more organizations, pooling their resources, expertise, and efforts to achieve common goals or objectives. For instance, in February 2022, Ono Pharmaceutical Co., Ltd., a Japan-based pharmaceutical company, and Bristol-Myers Squibb, a US-based biopharmaceutical company, forged an outsourcing agreement with Prime Research Institute for Medical Research, Inc., a Japan-based research institute, for a joint clinical research project focused on gastric cancer patients treated with Opdivo (nivolumab) in combination with chemotherapy. This collaborative initiative, sponsored by the industry, encompasses a large-scale, multi-institutional study employing PRiME-R's CyberOncology data input support system, facilitating the standardization, structuring, management, and integration of real-world data in routine cancer clinical practice. The clinical research, utilizing CyberOncology, assesses the effectiveness of Opdivo combined with chemotherapy for untreated advanced or recurrent gastric cancer. Involving approximately 30 medical institutions nationwide, the study aims to streamline data input, improve data accuracy, and expedite analysis.

In February 2022, Ono Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, entered into a collaboration with Bristol Myers Squibb K.K., a US-based multinational biopharmaceutical company. The partnership aims to conduct a large-scale, multi-institutional clinical research study to assess the efficacy and safety of Opdivo (nivolumab) in combination with chemotherapy for patients with advanced or recurrent gastric cancer. This initiative makes use of PRIMER's CyberOncology system, which standardizes and integrates real-world data from clinical practice, enhancing the accuracy and efficiency of the research process.

Major companies operating in the cancer immunotherapy drug discovery outsourcing market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings (LabCorp), Eurofins Scientific SE, WuXi AppTec Co Ltd., Charles River Laboratories International Inc., PerkinElmer Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Evotec SE, Shanghai ChemPartner Co. Ltd., Aragen Life Sciences Limited, GenScript Biotech Corporation, BGI Genomics Co. Ltd., NeoGenomics Laboratories Inc, ARUP Laboratories, Syngene International Limited, BioDuro-Sundia, Ambry Genetics Corporation, Selvita, Crown Bioscience International, CENTOGENE N.V., Jubilant Biosys, Oncodesign Services, Icagen Inc., Reaction Biology Corporation, ChemBridge Corporation

North America was the largest region in the cancer immunotherapy drug discovery outsourcing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer immunotherapy drug discovery outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cancer immunotherapy drug discovery outsourcing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cancer immunotherapy drug discovery outsourcing market includes revenues earned by entities by providing services such as preclinical testing, clinical trial support, and biomarker discovery. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer immunotherapy drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer immunotherapy drug discovery outsourcing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer immunotherapy drug discovery outsourcing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Monoclonal Antibodies; Immunomodulators; Oncolytic Viral Therapies And Cancer Vaccines; Other Drug Types
2) By Service Type: Target Identification And Validation; Lead Screening And Characterization; Cell-Based Assays
3) By Therapeutic Area: Lung Cancer; Breast Cancer; Melanoma; Other Therapeutic Areas
Subsegments:
1) By Monoclonal Antibodies: Checkpoint Inhibitors; Therapeutic Monoclonal Antibodies; Bispecific Antibodies; Antibody-Drug Conjugates (ADCs)
2) By Immunomodulators: Cytokines; Immune Checkpoint Modulators; Toll-Like Receptor Agonists; Immune Adjuvants
3) By Oncolytic Viral Therapies And Cancer Vaccines: Oncolytic Virus-Based Therapies; Cancer Vaccines; Viral Vectors For Immunotherapy
4) By Other Drug Types: Adoptive Cell Therapy; Immune Cell Modulators; Small Molecule Immune Modulators; Gene Editing And Immunotherapy
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Laboratory Corporation of America Holdings (LabCorp); Eurofins Scientific SE; WuXi AppTec Co Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r29690

1. Executive Summary

2. Cancer Immunotherapy Drug Discovery Outsourcing Market Characteristics

3. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends And Strategies

4. Cancer Immunotherapy Drug Discovery Outsourcing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cancer Immunotherapy Drug Discovery Outsourcing Growth Analysis And Strategic Analysis Framework

5.1. Global Cancer Immunotherapy Drug Discovery Outsourcing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Growth Rate Analysis
5.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Total Addressable Market (TAM)

6. Cancer Immunotherapy Drug Discovery Outsourcing Market Segmentation

6.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Monoclonal Antibodies
Immunomodulators
Oncolytic Viral Therapies And Cancer Vaccines
Other Drug Types
6.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Target Identification And Validation
Lead Screening And Characterization
Cell-Based Assays
6.3. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Lung Cancer
Breast Cancer
Melanoma
Other Therapeutic Areas
6.4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Monoclonal Antibodies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Checkpoint Inhibitors
Therapeutic Monoclonal Antibodies
Bispecific Antibodies
Antibody-Drug Conjugates (ADCs)
6.5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Immunomodulators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cytokines
Immune Checkpoint Modulators
Toll-Like Receptor Agonists
Immune Adjuvants
6.6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Oncolytic Viral Therapies And Cancer Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncolytic Virus-Based Therapies
Cancer Vaccines
Viral Vectors For Immunotherapy
6.7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Sub-Segmentation Of Other Drug Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Adoptive Cell Therapy
Immune Cell Modulators
Small Molecule Immune Modulators
Gene Editing And Immunotherapy

7. Cancer Immunotherapy Drug Discovery Outsourcing Market Regional And Country Analysis

7.1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cancer Immunotherapy Drug Discovery Outsourcing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market

8.1. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cancer Immunotherapy Drug Discovery Outsourcing Market

9.1. China Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
9.2. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cancer Immunotherapy Drug Discovery Outsourcing Market

10.1. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market

11.1. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
11.2. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market

12.1. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market

13.1. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market

14.1. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
14.2. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

15.1. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
15.2. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cancer Immunotherapy Drug Discovery Outsourcing Market

16.1. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market

17.1. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cancer Immunotherapy Drug Discovery Outsourcing Market

18.1. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market

19.1. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market

20.1. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market

21.1. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
21.2. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market

22.1. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market

23.1. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
23.2. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cancer Immunotherapy Drug Discovery Outsourcing Market

24.1. USA Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
24.2. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market

25.1. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
25.2. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cancer Immunotherapy Drug Discovery Outsourcing Market

26.1. South America Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
26.2. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market

27.1. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market

28.1. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
28.2. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market

29.1. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Overview
29.2. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Service Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cancer Immunotherapy Drug Discovery Outsourcing Market, Segmentation By Therapeutic Area, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape And Company Profiles

30.1. Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Landscape
30.2. Cancer Immunotherapy Drug Discovery Outsourcing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Laboratory Corporation of America Holdings (LabCorp) Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. WuXi AppTec Co Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Cancer Immunotherapy Drug Discovery Outsourcing Market Other Major And Innovative Companies

31.1. Charles River Laboratories International Inc.
31.2. PerkinElmer Inc
31.3. Bio-Rad Laboratories Inc
31.4. QIAGEN N.V.
31.5. Evotec SE
31.6. Shanghai ChemPartner Co. Ltd.
31.7. Aragen Life Sciences Limited
31.8. GenScript Biotech Corporation
31.9. BGI Genomics Co. Ltd.
31.10. NeoGenomics Laboratories Inc
31.11. ARUP Laboratories
31.12. Syngene International Limited
31.13. BioDuro-Sundia
31.14. Ambry Genetics Corporation
31.15. Selvita

32. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cancer Immunotherapy Drug Discovery Outsourcing Market

34. Recent Developments In The Cancer Immunotherapy Drug Discovery Outsourcing Market

35. Cancer Immunotherapy Drug Discovery Outsourcing Market High Potential Countries, Segments and Strategies

35.1 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Countries Offering Most New Opportunities
35.2 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Segments Offering Most New Opportunities
35.3 Cancer Immunotherapy Drug Discovery Outsourcing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer